Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the chronic functional and histopathological changes in the sciatic nerve and lens of streptozotocin (STZ)-diabetic rats and evaluated the preventive effects of ranirestat (AS-3201), a potent aldose reductase inhibitor, on these changes. Sorbitol levels in the sciatic nerve and lens, motor nerve conduction velocity (MNCV), and development of cataracts were measured in STZ-diabetic rats given a ranirestat-admixed diet (0.0005%) for 35 weeks. Ranirestat reduced sorbitol accumulation in the sciatic nerve and improved the decrease in MNCV of STZ-diabetic rats. Morphological and morphometric examination of changes in sural nerve revealed that treatment with ranirestat prevented both the deformity of myelinated fibers and the decrease in their axonal and myelin areas (atrophy). Ranirestat also averted the changes in the size frequency histogram of myelinated fibers. Finally, STZ-diabetic rats developed early lens opacities 8 weeks after STZ injection and had cataract by the end of the experimental period. However, in the ranirestat-treated diabetic rats, no lens opacity was observed in any rat throughout the entire experimental period. This study suggests that the polyol pathway plays an important role in the progress of diabetic neuropathy and cataract formation in STZ-diabetic rats. Ranirestat should be a promising agent for the treatment of complications associated with diabetes, especially neuropathy.
- 社団法人 日本薬理学会の論文
- 2008-07-20
著者
-
Toyosawa Kaoru
Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd.
-
Toyosawa Kaoru
Safety Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Ono Yoshiyuki
International Business Management Dainippon Sumitomo Pharma Co. Ltd.
-
MATSUMOTO Takafumi
Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd.
-
KUROMIYA Akemi
Genomic Science Laboratories, Dainippon Sumitomo Pharma Co., Ltd.
-
BRIL Vera
Department of Medicine, University of Toronto EN11-209, Toronto General Hospital
-
UEDA Yoshinaka
Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd.
-
Bril Vera
Department Of Medicine University Of Toronto En11-209 Toronto General Hospital
-
Ueda Yoshinaka
Safety Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Kuromiya Akemi
Genomic Science Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Matsumoto Takafumi
Pharmacology Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
関連論文
- The First Case of Feline Infectious Peritonitis-like Pyogranuloma in a Ferret Infected by Coronavirus in Japan
- A Novel "Nihon" Rat Model of a Mendelian Dominantly Inherited Renal Cell Carcinoma
- Improvement of Motor Nerve Conduction Velocity in Diabetic Rats Requires Normalization of the Polyol Pathway Metabolites Flux
- Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats
- Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats
- Application of Prohibitin Immunohistochemistry to Rat Livers Treated with Methapyrilene Hydrochloride
- Mucinous Adenocarcinoma of the Jejunum in a F344 Rat
- Spontaneous Fibrosarcoma with Pleomorphic Appearance in an Aged Brown Norway Rat
- Application of Prohibitin Immunohistochemistry to Rat Livers Treated with Methapyrilene Hydrochloride
- Immunohistochemical and Ultrastructural Analyses of Cytoplasmic Blood Plasma Inclusions of Rat Hepatocytes
- Cystic Cholangioma in the Thoracic Cavity of a Rat
- The First Case of Feline Infectious Peritonitis-like Pyogranuloma in a Ferret Infected by Coronavirus in Japan
- Spontaneous Fibrosarcoma with Pleomorphic Appearance in an Aged Brown Norway Rat
- Immunohistochemical and Ultrastructural Analyses of Cytoplasmic Blood Plasma Inclusions of Rat Hepatocytes
- Immunohistochemical and Ultrastructural Analyses of Cytoplasmic Blood Plasma Inclusions of Rat Hepatocytes